Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kalmon D Post

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Journal of Neuro-Oncology|February 21, 2021
Fluorescence guided surgery for pituitary adenomasNikita Lakomkin, Jamie J Van Gompel, Kalmon D Post, et al.
Clinical Endocrinology|May 29, 2009
Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosedTirissa J Reid, Kalmon D Post, Jeffrey N Bruce, et al.
Clinical Endocrinology|June 17, 2014
Predictors of quality of life in 102 patients with treated Cushing's diseaseAlessia Carluccio, Nina K Sundaram, Sumedha Chablani, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2011
Pituitary incidentaloma: an endocrine society clinical practice guidelinePamela U Freda, Albert M Beckers, Laurence Katznelson, et al.
Neurosurgery|August 15, 2025
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for the Role of Imaging for Patients With Functioning Pituitary AdenomasJacqueline C Junn, Kalmon D Post, Manish K Aghi, et al.
Pituitary|October 30, 2020
Prognostic value of nadir GH levels for long-term biochemical remission or recurrence in surgically treated acromegalyPamela U Freda, Jeffrey N Bruce, Carlos Reyes-Vidal, et al.
Pituitary|June 28, 2007
Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remissionPamela U Freda, Wendy K Chung, Naoki Matsuoka, et al.
Journal of Neurosurgery|March 11, 2022
Seventy-five years of neurosurgery residency training at The Mount Sinai HospitalMatthew T Carr, Jeffrey H Zimering, Jillian M Beroza, et al.
The Journal of Clinical Endocrinology and Metabolism|August 20, 2014
Prospective study of surgical treatment of acromegaly: effects on ghrelin, weight, adiposity, and markers of CV riskCarlos Reyes-Vidal, Jean Carlos Fernandez, Jeffrey N Bruce, et al.
Pituitary|April 25, 2015
IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body compositionTirissa J Reid, Zhezhen Jin, Wei Shen, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Neuro-Oncology|February 21, 2021
Fluorescence guided surgery for pituitary adenomasNikita Lakomkin, Jamie J Van Gompel, Kalmon D Post, et al.
Clinical Endocrinology|May 29, 2009
Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosedTirissa J Reid, Kalmon D Post, Jeffrey N Bruce, et al.
Clinical Endocrinology|June 17, 2014
Predictors of quality of life in 102 patients with treated Cushing's diseaseAlessia Carluccio, Nina K Sundaram, Sumedha Chablani, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2011
Pituitary incidentaloma: an endocrine society clinical practice guidelinePamela U Freda, Albert M Beckers, Laurence Katznelson, et al.
Neurosurgery|August 15, 2025
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for the Role of Imaging for Patients With Functioning Pituitary AdenomasJacqueline C Junn, Kalmon D Post, Manish K Aghi, et al.
Pituitary|October 30, 2020
Prognostic value of nadir GH levels for long-term biochemical remission or recurrence in surgically treated acromegalyPamela U Freda, Jeffrey N Bruce, Carlos Reyes-Vidal, et al.
Pituitary|June 28, 2007
Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remissionPamela U Freda, Wendy K Chung, Naoki Matsuoka, et al.
Journal of Neurosurgery|March 11, 2022
Seventy-five years of neurosurgery residency training at The Mount Sinai HospitalMatthew T Carr, Jeffrey H Zimering, Jillian M Beroza, et al.
The Journal of Clinical Endocrinology and Metabolism|August 20, 2014
Prospective study of surgical treatment of acromegaly: effects on ghrelin, weight, adiposity, and markers of CV riskCarlos Reyes-Vidal, Jean Carlos Fernandez, Jeffrey N Bruce, et al.
Pituitary|April 25, 2015
IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body compositionTirissa J Reid, Zhezhen Jin, Wei Shen, et al.
Pageof 5